Showing results (221-230 of 343) with videos related to
Sort By:
Pageof 35
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 3, 2020
Systemic inflammation as fuel for acute liver injury in COVID-19Maria Effenberger, Christoph Grander, Felix Grabherr, et al.Obesity (Silver Spring, Md.)|May 15, 2007
Effects of pronounced weight loss on adiponectin oligomer composition and metabolic parametersJulia Engl, Thomas Bobbert, Christian Ciardi, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2020
Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin diseaseAndré Viveiros, Marlene Panzer, Nadja Baumgartner, et al.European Cytokine Network|February 12, 2010
Influence of significant weight loss on serum matrix metalloproteinase (MMP)-7 levelsClaudia Ress, Alexander Tschoner, Christian Ciardi, et al.Clinical Immunology (Orlando, Fla.)|September 24, 2004
Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel diseaseAnna Maria Wolf, Dominik Wolf, Holger Rumpold, et al.Trends in Endocrinology and Metabolism: TEM|June 22, 2024
Recompensation in MASLD-related cirrhosis via metabolic bariatric surgeryGong Feng, Yu Han, Wah Yang, et al.Viruses|January 26, 2024
B and T Cell Responses to SARS-CoV-2 Vaccination in Kidney and Liver Transplant Recipients with and without Previous COVID-19Christina Watschinger, Gerald Stampfel, Andreas Zollner, et al.Cellular and Molecular Gastroenterology and Hepatology|October 8, 2021
Tofacitinib-Induced Modulation of Intestinal Adaptive and Innate Immunity and Factors Driving Cellular and Systemic PharmacokineticsBernhard Texler, Andreas Zollner, Vera Reinstadler, et al.Journal of Crohn'S & Colitis|June 20, 2020
Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative StudyAndreas Zollner, Andreas Schmiderer, Simon J Reider, et al.Obesity (Silver Spring, Md.)|June 7, 2008
A-FABP--a biomarker associated with the metabolic syndrome and/or an indicator of weight change?Julia Engl, Christian Ciardi, Tobias Tatarczyk, et al.Pageof 35